PP
AMED

Paloma Partners’s Amedisys AMED Stock Holding History

Paloma Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,775
Closed -$1.91M – 1045
2021
Q2 		$1.91M Buy
7,775
+6,515
+517% +$1.71M 0.03% 432
2021
Q1 		$334K Buy
+1,260
New +$355K 0.01% 1403
2020
Q4 		– Sell
-7,735
Closed -$1.83M – 1611
2020
Q3 		$1.83M Sell
7,735
-64,714
-89% -$14.7M 0.05% 421
2020
Q2 		$14.4M Buy
72,449
+70,777
+4,233% +$13.2M 0.25% 59
2020
Q1 		$307K Sell
1,672
-3,530
-68% -$628K 0.02% 679
2019
Q4 		$869K Buy
+5,202
New +$774K 0.01% 1030
2019
Q2 		– Sell
-8,443
Closed -$1.04M – 1701
2019
Q1 		$1.04M Buy
8,443
+4,718
+127% +$592K 0.03% 709
2018
Q4 		$436K Sell
3,725
-21,772
-85% -$2.57M 0.01% 725
2018
Q3 		$3.19M Buy
+25,497
New +$2.82M 0.06% 296
2018
Q2 		– Sell
-6,903
Closed -$416K – 1591
2018
Q1 		$416K Buy
6,903
+1,019
+17% +$58K 0.01% 1470
2017
Q4 		$310K Buy
+5,884
New +$310K ﹤0.01% 1535
2017
Q3 		– Sell
-15,618
Closed -$981K – 2070
2017
Q2 		$981K Sell
15,618
-26,651
-63% -$1.55M 0.01% 1210
2017
Q1 		$2.16M Buy
42,269
+6,947
+20% +$331K 0.03% 738
2016
Q4 		$1.5M Buy
+35,322
New +$1.5M 0.01% 877
2015
Q4 		– Sell
-9,693
Closed -$368K – 1683
2015
Q3 		$368K Buy
+9,693
New +$409K 0.01% 1189
2014
Q3 		– Sell
-21,428
Closed -$359K – 995
2014
Q2 		$359K Buy
+21,428
New +$304K 0.01% 735

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Paloma Partners's AMED Position: Q3 2021 in Review

Paloma Partners sold out of Amedisys (AMED) in Q3 2021, closing a stake of 7,775 shares — an estimated $1.91M sold.

Paloma Partners first reported a position in AMED in Q2 2014 and held it in 16 quarters. The position peaked at $14.4M in Q2 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Paloma Partners reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Paloma Partners sold 7,775 Amedisys shares in Q3 2021, an estimated $1.91M.
  • Paloma Partners first reported a position in Amedisys in Q2 2014 and held it in 16 quarters.
  • Paloma Partners's Amedisys position peaked at $14.4M in Q2 2020.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Paloma Partners's 13F filing for Q3 2021, filed 15 Nov 2021.